The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting.
Omicron is the comparatively most transmissible and contagious variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). We conducted a seroprevalence study from March 1-3, 2022, to investigate the seroprevalence of SARS-CoV-2 antibodies among individuals aged 18 years and older after...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLOS Global Public Health |
| Online Access: | https://doi.org/10.1371/journal.pgph.0003893 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555281170923520 |
|---|---|
| author | Ching-Wen Hou Stacy Williams Guillermo Trivino-Soto Veronica Boyle David Rainford Selina Vicino Mitch Magee Yunro Chung Joshua LaBaer Vel Murugan |
| author_facet | Ching-Wen Hou Stacy Williams Guillermo Trivino-Soto Veronica Boyle David Rainford Selina Vicino Mitch Magee Yunro Chung Joshua LaBaer Vel Murugan |
| author_sort | Ching-Wen Hou |
| collection | DOAJ |
| description | Omicron is the comparatively most transmissible and contagious variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). We conducted a seroprevalence study from March 1-3, 2022, to investigate the seroprevalence of SARS-CoV-2 antibodies among individuals aged 18 years and older after the Omicron outbreak. The seroprevalence of anti-receptor binding domain (RBD) antibodies was found to be 96.3% (95% CI 95.2-97.2%) compared to 88.2% (95% CI 86.1-90%) in our previous serosurvey. For anti-nucleocapsid (NC) antibodies, the seroprevalence was 39.1% (95% CI 36.6-41.7%) compared to 19.7% (95% CI 17.5-22.2%) earlier. Individuals that experienced breakthrough infections exhibited the highest levels of anti-RBD antibodies. Additionally, saliva samples showed promise as a potential diagnostic biofluid for measuring antibody levels, as they exhibited a strong agreement with the data obtained from serum samples. The near doubling of anti-NC reactivity, a proxy for history of infection, reflects the contagiousness of the omicron variant, but may also have been influenced by a more relaxed approach to precautions in the spring of 2022. Serosurveys repeated at regular intervals monitor the trend of infections in the community, delineate the geographical spread of the infection, and may guide containment measures in communities, and prompt response to future outbreaks. |
| format | Article |
| id | doaj-art-f02d58b712ef4eb0a1d4b6fb303e01e4 |
| institution | Kabale University |
| issn | 2767-3375 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLOS Global Public Health |
| spelling | doaj-art-f02d58b712ef4eb0a1d4b6fb303e01e42025-01-08T05:51:30ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752025-01-0151e000389310.1371/journal.pgph.0003893The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting.Ching-Wen HouStacy WilliamsGuillermo Trivino-SotoVeronica BoyleDavid RainfordSelina VicinoMitch MageeYunro ChungJoshua LaBaerVel MuruganOmicron is the comparatively most transmissible and contagious variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). We conducted a seroprevalence study from March 1-3, 2022, to investigate the seroprevalence of SARS-CoV-2 antibodies among individuals aged 18 years and older after the Omicron outbreak. The seroprevalence of anti-receptor binding domain (RBD) antibodies was found to be 96.3% (95% CI 95.2-97.2%) compared to 88.2% (95% CI 86.1-90%) in our previous serosurvey. For anti-nucleocapsid (NC) antibodies, the seroprevalence was 39.1% (95% CI 36.6-41.7%) compared to 19.7% (95% CI 17.5-22.2%) earlier. Individuals that experienced breakthrough infections exhibited the highest levels of anti-RBD antibodies. Additionally, saliva samples showed promise as a potential diagnostic biofluid for measuring antibody levels, as they exhibited a strong agreement with the data obtained from serum samples. The near doubling of anti-NC reactivity, a proxy for history of infection, reflects the contagiousness of the omicron variant, but may also have been influenced by a more relaxed approach to precautions in the spring of 2022. Serosurveys repeated at regular intervals monitor the trend of infections in the community, delineate the geographical spread of the infection, and may guide containment measures in communities, and prompt response to future outbreaks.https://doi.org/10.1371/journal.pgph.0003893 |
| spellingShingle | Ching-Wen Hou Stacy Williams Guillermo Trivino-Soto Veronica Boyle David Rainford Selina Vicino Mitch Magee Yunro Chung Joshua LaBaer Vel Murugan The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. PLOS Global Public Health |
| title | The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. |
| title_full | The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. |
| title_fullStr | The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. |
| title_full_unstemmed | The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. |
| title_short | The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. |
| title_sort | omicron variant of sars cov 2 drove broadly increased seroprevalence in a public university setting |
| url | https://doi.org/10.1371/journal.pgph.0003893 |
| work_keys_str_mv | AT chingwenhou theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT stacywilliams theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT guillermotrivinosoto theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT veronicaboyle theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT davidrainford theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT selinavicino theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT mitchmagee theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT yunrochung theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT joshualabaer theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT velmurugan theomicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT chingwenhou omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT stacywilliams omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT guillermotrivinosoto omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT veronicaboyle omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT davidrainford omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT selinavicino omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT mitchmagee omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT yunrochung omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT joshualabaer omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting AT velmurugan omicronvariantofsarscov2drovebroadlyincreasedseroprevalenceinapublicuniversitysetting |